Sagimet Biosciences
We are a clinical-stage biopharmaceutical company advancing a portfolio of novel fatty acid synthase (FASN) inhibitors.
$7M Series B+ ·
Source: startupintros.com
Latest round on record: Series A, April 2026, amount undisclosed.
Total raised: $25M across 2 sourced rounds
All 3 rounds ↓Signals
Website registeredMar 28, 2019 (7 years old)
About Sagimet Biosciences
FASN is a key […]
TIMELINE · MONEY RAISED
Sagimet Biosciences | 2832 days on the record
Raised $25M in 2 sourced rounds
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | — | fundraisingfox.com | |
| Series B+ | $7M | — | startupintros.com | |
| Series B+ | $18M | — | startupintros.com |
Timeline
- Website created
Companies like Sagimet Biosciences
AApollo Therapeutics$226.5M Series B+ · Sep 2023CCellCentric$220M Series B+ · May 2026
SStorm Therapeutics$56M Series B+ · Apr 2026
RR1 Therapeutics$80.5M Series A · Sep 2026
LLifeMine Therapeutics$75M Series B+ · Aug 2026
AAdjuvia Therapeutics$8M Seed · Jul 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/sagimet-biosciences (get a free API key).